Bluestar-Endometrial01 trial: what clinicians have said so far
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- NCT07044336 ↗
- Recruiting
- AstraZeneca
- Focused size, estimated: 1–150 verified statements once built
Discussed at: 2026 ASCO Annual Meeting
We haven't built an HCP commentary report on Bluestar-Endometrial01 (puxitatug samrotecan (AZD8205) in B7-H4-selected advanced/metastatic endometrial cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on Bluestar-Endometrial01 so far
Podcasts, YouTube videos and posts on X and Bluesky we have indexed that name the trial. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 2 YouTube videos, typically up to 9 once built | |
| 1 podcast episode, typically up to 4 once built | |
| 1 post on X, typically up to 4 once built |
The trial
ClinicalTrials.gov- Official title
- Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4 Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (Bluestar-Endometrial01)
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Endometrial Cancer; Malignant Solid Tumour
- Interventions
- Puxitatug Samrotecan; Doxorubicin; Paclitaxel
- Arms
- Puxitatug Samrotecan · Experimental
- Chemotherapy · Active comparator
- Enrollment
- 800 (estimated)
- Primary outcomes
- Progression Free Survival (PFS) for Arm A vs Arm B
- Overall survival (OS) for Arm A vs Arm B
- Sponsor
- AstraZeneca
- Start
- Aug 1, 2025
- Primary completion
- Oct 15, 2027 (estimated)
- Results posted
- No
- Registry record
- NCT07044336 · updated Jul 29, 2026